Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.
Journal of addiction medicine May 28, 2025 Sara Prostko, Alexander Wu, Samuel Maddams et al. 2 citations
Among 192 adults with alcohol use disorder, opioid use disorder, or psychiatric disorders surveyed at a large hospital, 66% had previously tried psychedelics, 72.4% believed psychedelics could help patients with substance use or psychiatric disorders, and 69.8% said they would personally try psychedelic-assisted treatment for such a condition. Willingness to try psychedelic treatment was significantly higher among those who had previously used psilocybin (90.0% vs. 47.8%), MDMA (89.7% vs. 61.2%), or ketamine (100% vs. 65.7%). Participants opposed to psychedelic treatment were more likely to perceive risks including depression, anxiety, heart damage, brain damage, and addiction. The authors conclude that further safety trials and educational interventions are needed.